Morning and afternoon serum cortisol level in patients with post-myocardial infarction depression

Alina Wilkowska1, Andrzej Rynkiewicz2, Joanna Wdowczyk3

  • 1Department of Adult Psychiatry, Medical University of Gdansk, Poland. ali.wilkowska@gmail.com.

Cardiology Journal
|October 25, 2017
PubMed

Insights

Post-myocardial depression, a common issue after heart attacks, is linked to altered cortisol levels. Patients with depression showed a flattened diurnal cortisol profile, impacting their recovery and prognosis.

Area of Science:

  • Cardiology
  • Endocrinology
  • Psychiatry

Background:

  • Post-myocardial infarction depression is a prevalent complication.
  • It negatively impacts the prognosis of coronary artery disease.
  • Hypothalamic-pituitary-adrenal axis dysregulation and cortisol disturbances are potential pathogenetic factors.

Purpose of the Study:

  • To investigate the relationship between post-myocardial infarction depression and diurnal cortisol profiles.
  • To assess cortisol levels in patients experiencing their first myocardial infarction.

Main Methods:

  • Thirty-seven patients hospitalized for a first myocardial infarction were included.
  • Depressive symptoms were assessed using the Beck Depression Inventory (BDI).
  • Morning and afternoon serum cortisol samples were collected on day five post-MI.

Main Results:

  • Depression (BDI ≥ 10) was diagnosed in 34.4% of patients.
  • A significant difference in diurnal cortisol profiles was observed between depressed and non-depressed patients (p = 0.0328).
  • Depressed patients exhibited a flattened diurnal serum cortisol pattern.

Conclusions:

  • Depressive symptoms following myocardial infarction are associated with a flattened diurnal cortisol profile.
  • This flattened profile is more pronounced in patients with longer-lasting depressive symptoms.
  • Cortisol dysregulation may play a role in the pathophysiology of post-MI depression.
Abstract

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
309
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
947
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
625
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response01:15

Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response

Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
402
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
437
Depressive Disorders: MDD and Dysthymia01:27

Depressive Disorders: MDD and Dysthymia

Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
858